- Home
- Clinical Trials
Herpes Simplex Virus Study Kapiti ABI
Herpes Simplex Virus (HSV) Study
Kapiti
Did you know that Herpes Simplex Virus (HSV-2) is widely prevalent and can be transmitted to sexual partners even when no symptoms are present?
We invite you to participate in a clinical research study for a potential long-acting oral medication that aims to supress recurrent episodes of genital herpes.
Register your interest now and find out if participating in this study is right for you. Your privacy is important to us, and all information shared will be kept confidential.
Participants will be reimbursed.
Description
What to expect
Study details
Ages
18 - 60 years old
Duration
29 days of treatment and a minimum 18 clinic visits across 172 days
Compensation
Eligible participants will be creimbursed
Eligibility Criteria
You may be eligible to participate if you:
- Are 18 to 60 years old
- Have recurrent episodes of genital herpes (HSV-2)
- Are otherwise in good health
Other eligibility criteria will apply
Locations
Description
The Herpes Simplex Virus 2 (HSV-2) is a chronic long-term condition that causes genital ulcers. It is widely prevalent, with an estimated 13.2% or 491.5 million people aged 15-49 years worldwide living with HSV-2.
HSV-2 can lie dormant in nerve cells and become active again with periodic viral shedding episodes that cause unpleasant recurrent symptoms in some people as well as the risk of transmission to sexual partners.
Current treatment with antiviral medication is only partially effective in preventing recurrences and transmission to others. There is need for more potent, long-acting antiviral therapy.
What to expect
Momentum Clinical Research are conducting a clinical study for a potential long-acting oral antiviral medication that aims to suppress recurrent episodes of genital herpes.
Participants will receive treatment over a 29 day period and will come into the clinic for a minimum of 18 appointments across 172 days.
Your contribution to this study will help evaluate the safety and tolerability of a potential new medication that may improve the lives of people in our communities that suffer from this chronic condition and protect the sexual health of others.
Register now and find out if this study is right for you.
This research is funded by Assembly Biosciences Inc. Approved by Northern B Ethics committee (19873)
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.